Tech Company Financing Transactions

Adimab Funding Round

On 4/2/2012, Adimab announced Series F funding from private investors.

Transaction Overview

Company Name
Announced On
4/2/2012
Transaction Type
Venture Equity
Amount
Unknown
Round
Series F
Investors
Proceeds Purpose
We are accelerating the expansion of our platform to include additional applications such as the development of bi-specific antibodies, antibody-drug conjugates, targeting cell based antigens including GPCRs and ion channels, as well as preclinical manufacturing and mammalian cell line development.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
7 Lucent Dr.
Lebanon, NH 03766
USA
Email Address
Overview
Adimab is an antibody discovery and optimization platform, developing full-length human Immunoglobulin Gs.
Profile
Adimab LinkedIn Company Profile
Social Media
Adimab Company Twitter Account
Company News
Adimab News
Facebook
Adimab on Facebook
YouTube
Adimab on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Tillman Gerngross
  Tillman Gerngross LinkedIn Profile  Tillman Gerngross Twitter Account  Tillman Gerngross News  Tillman Gerngross on Facebook
Chief Financial Officer
Ryan McGovern
  Ryan McGovern LinkedIn Profile  Ryan McGovern Twitter Account  Ryan McGovern News  Ryan McGovern on Facebook
Chief Scientific Officer
Eric Krauland
  Eric Krauland LinkedIn Profile  Eric Krauland Twitter Account  Eric Krauland News  Eric Krauland on Facebook
Co-Founder
Dane Wittrup
  Dane Wittrup LinkedIn Profile  Dane Wittrup Twitter Account  Dane Wittrup News  Dane Wittrup on Facebook
VP - Bus. Development
Guy Meter
  Guy Meter LinkedIn Profile  Guy Meter Twitter Account  Guy Meter News  Guy Meter on Facebook
VP - General Counsel
Philip Chase
  Philip Chase LinkedIn Profile  Philip Chase Twitter Account  Philip Chase News  Philip Chase on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/2/2012: Emerald Therapeutics venture capital transaction
Next: 4/2/2012: Good Start Genetics venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on funding rounds that are announced publicly. VC transactions reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary